SCHEMBL20428406

SCHEMBL20428406

COc1ccc(N(C)C)cc1OS(=O)(=O)c1ccc(F)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NR1H4 Q96RI1 1/20 0.43
ALDH1A1 P00352 6/20 0.42
LMNA P02545 4/20 0.42
HTT P42858 2/20 0.42
MAPK1 P28482 2/20 0.42
HPGD P15428 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PKM P14618 1/20 0.41
POLB P06746 1/20 0.41
TSHR P16473 1/20 0.41
MAPT P10636 4/20 0.41
HCRTR2 O43614 1/20 0.41
SLC6A4 P31645 1/20 0.40
PTGS2 P35354 1/20 0.40
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
NQO2 P16083 1/20 0.39
KDM4E B2RXH2 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29741648 0.79 LMNA (0.61) NR1H4ALDH1A1LMNAHTTMAPK1
SCHEMBL20428405 0.76 NR1H4 (0.41) NR1H4ALDH1A1LMNAHTTMAPK1
SCHEMBL21687439 0.73 NR1H4 (0.41) NR1H4ALDH1A1LMNAHTTMAPK1
SCHEMBL1107760 0.73 NQO2 (0.63) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL6341347 0.71 TUBB4A (0.54) ALDH1A1LMNAHTTMAPK1SMN1; SMN2
SCHEMBL6938287 0.71 GFER (0.54) ALDH1A1LMNAHTTHPGDSMN1; SMN2
SCHEMBL6799209 0.70 MAPT (0.52) ALDH1A1HPGDSMN1; SMN2POLBMAPT
SCHEMBL8628798 0.70 APP (0.44) ALDH1A1LMNAMAPK1HPGDPOLB
SCHEMBL10829117 0.69 CA1 (0.49) ALDH1A1LMNAMAPK1HPGDSMN1; SMN2
SCHEMBL9957765 0.69 KDM4E (0.49) ALDH1A1LMNAHTTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3354648-A1 4-SUBSTITUED COUMARIN DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF Guizhou Bailing Group Pharmaceutical Co., Ltd. (CN) 2018-08-01 EP disclosed